No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
DCEMRI of breast lesions: Is kinetic analysis equally effective for both mass and nonmass-like enhancement?
1.D. C. Abraham, R. C. Jones, S. E. Jones, J. H. Cheek, G. N. Peters, S. M. Knox, M. D. Grant, D. W. Hampe, D. A. Savino, and S. E. Harms, “Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging,” Cancer 78, 91–100 (1996).
2.C. Boetes, R. D. Mus, R. Holland, J. O. Barentsz, S. P. Strijk, T. Wobbes, J. H. Hendriks, and S. H. Ruys, “Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent,” Radiology 197, 743–747 (1995).
3.C. K. Kuhl and H. H. Schild, “Dynamic image interpretation of MRI of the breast,” J. Magn. Reson Imaging 12, 965–974 (2000).
4.W. Chen, M. L. Giger, U. Bick, and G. M. Newstead, “Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI,” Med. Phys. 33, 2878–2887 (2006).
5.G. O. Cron, F. Kelcz, and G. E. Santyr, “Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T(1) measurements,” Magn. Reson. Med. 51, 1066–1070 (2004).
6.P. Armitage, C. Behrenbruch, M. Brady, and N. Moore, “Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast,” Med. Image Anal. 9, 315–329 (2005).
7.E. Furman-Haran, E. Schechtman, F. Kelcz, K. Kirshenbaum, and H. Degani, “Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions,” Cancer 104, 708–718 (2005).
8.P. S. Tofts, B. Berkowitz, and M. D. Schnall, “Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model,” Magn. Reson. Med. 33, 564–568 (1995).
9.X. Fan, M. Medved, G. S. Karczmar, C. Yang, S. Foxley, S. Arkani, W. Recant, M. A. Zamora, H. Abe, and G. M. Newstead, “Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI,” Magn. Reson. Imaging 25, 593–603 (2007).
10.E. V. Heiberg, W. H. Perman, V. M. Herrmann, and C. G. Janney, “Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast,” Magn. Reson. Imaging 14, 337–348 (1996).
12.X. Fan, M. Medved, J. N. River, M. Zamora, C. Corot, P. Robert, P. Bourrinet, M. Lipton, R. M. Culp, and G. S. Karczmar, “New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors,” Magn. Reson. Med. 51, 487–494 (2004).
13.S. A. Jansen, G. Newstead, H. Abe, A. Shimauchi, R. Schmidt, and G. S. Karczmar, “MR imaging of pure ductal carcinoma in situ: Kinetics, morphology and comparison with mammographic presentation and nuclear grade,” Radiology 245, 684–691 (2007).
14.H. Neubauer, M. Li, R. Kuehne-Heid, A. Schneider, and W. A. Kaiser, “High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: Characteristic findings for signal increase and morphological pattern of enhancement,” Br. J. Radiol. 76, 3–12 (2003).
15.J. H. Menell, E. A. Morris, D. D. Dershaw, A. F. Abramson, E. Brogi, and L. Liberman, “Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging,” Breast J. 11, 382–390 (2005).
16.M. Van Goethem, K. Schelfout, E. Kersschot, C. Colpaert, J. Weyler, I. Verslegers, I. Biltjes, A. De Schepper, and P. M. Parizel, “Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast,” Jbr-Btr 88, 225–232 (2005).
17.C. Kuhl, “The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice,” Radiology 244, 356–378 (2007).
18.A. Recht, E. J. Rutgers, I. S. Fentiman, J. M. Kurtz, R. E. Mansel, and J. P. Sloane, “The fourth EORTC DCIS Consensus meeting (Chateau Marquette, Heemskerk, The Netherlands, 23–24 January 1998)—conference report,” Eur. J. Cancer 34, 1664–1669 (1998).
19.T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, and N. Kamata, “Early breast cancer,” Int. J. Clin. Oncol. 11, 108–119 (2006).
20.C. K. Kuhl, S. Schrading, H. B. Bieling, E. Wardelmann, C. C. Leutner, R. Koenig, W. Kuhn, and H. H. Schild, “MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study,” Lancet 370, 485–492 (2007).
21.P. Viehweg, D. Lampe, J. Buchmann, and S. H. Heywang-Kobrunner, “In situ and minimally invasive breast cancer: Morphologic and kinetic features on contrast-enhanced MR imaging,” Magn. Reson. Mater. Phys., Biol., Med. 11, 129–137 (2000).
22.R. Gilles, B. Zafrani, J. M. Guinebretiere, M. Meunier, O. Lucidarme, A. A. Tardivon, F. Rochard, D. Vanel, S. Neuenschwander, and R. Arriagada, “Ductal carcinoma in situ: MR imaging-histopathologic correlation,” Radiology 196, 415–419 (1995).
23.A. Shiraishi, Y. Kurosaki, T. Maehara, M. Suzuki, and M. Kurosumi, “Extension of ductal carcinoma in situ: Histopathological association with MR imaging and mammography,” Magn. Reson. Med. Sci. 2, 159–163 (2003).
24.A. P. Schouten van der Velden, C. Boetes, P. Bult, and T. Wobbes, “The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma,” Am. J. Surg. 192, 172–178 (2006).
25.S. G. Orel, “MR imaging of the breast,” Radiol. Clin. North Am. 38, 899–913 (2000).
26.J. M. Lee, J. B. Kaplan, M. P. Murray, M. Mazur-Grbec, T. Tadic, D. Stimac, and L. Liberman, “Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy,” AJR, Am. J. Roentgenol. 189, 468–474 (2007).
27.K. J. Macura, R. Ouwerkerk, M. A. Jacobs, and D. A. Bluemke, “Patterns of enhancement on breast MR images: Interpretation and imaging pitfalls,” Radiographics 26, 1719–1734; quiz 1719 (2006).
28.D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, R. A. Smith, E. Warner, M. Yaffe, K. S. Andrews, and C. A. Russell, “American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography,” Ca-Cancer J. Clin. 57, 75–89 (2007).
29.L. Bartella, S. B. Thakur, E. A. Morris, D. D. Dershaw, W. Huang, E. Chough, M. C. Cruz, and L. Liberman, “Enhancing nonmass lesions in the breast: Evaluation with proton (1H) MR spectroscopy,” Radiology 245, 80–87 (2007).
30.L. Bartella, L. Liberman, E. A. Morris, and D. D. Dershaw, “Nonpalpable mammographically occult invasive breast cancers detected by MRI,” AJR, Am. J. Roentgenol. 186, 865–870 (2006).
31.M. A. van den Bosch, B. L. Daniel, M. N. Mariano, K. N. Nowels, R. L. Birdwell, K. J. Fong, P. S. Desmond, S. Plevritis, L. A. Stables, M. Zakhour, R. J. Herfkens, and D. M. Ikeda, “Magnetic resonance imaging characteristics of fibrocystic change of the breast,” Invest. Radiol. 40, 436–441 (2005).
32.L. Liberman, E. A. Morris, D. D. Dershaw, A. F. Abramson, and L. K. Tan, “Ductal enhancement on MR imaging of the breast,” AJR, Am. J. Roentgenol. 181, 519–525 (2003).
33.L. Liberman, E. A. Morris, M. J. Lee, J. B. Kaplan, L. R. LaTrenta, J. H. Menell, A. F. Abramson, S. M. Dashnaw, D. J. Ballon, and D. D. Dershaw, “Breast lesions detected on MR imaging: Features and positive predictive value,” AJR, Am. J. Roentgenol. 179, 171–178 (2002).
34.P. J. Moate, L. Dougherty, M. D. Schnall, R. J. Landis, and R. C. Boston, “A modified logistic model to describe gadolinium kinetics in breast tumors,” Magn. Reson. Imaging 22, 467–473 (2004).
35.J. L. Evelhoch, “Key factors in the acquisition of contrast kinetic data for oncology,” J. Magn. Reson Imaging 10, 254–259 (1999).
36.B. K. Szabo, P. Aspelin, M. K. Wiberg, and B. Bone, “Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria,” Acta Radiol. 44, 379–386 (2003).
37.L. D. Buadu, J. Murakami, S. Murayama, N. Hashiguchi, S. Sakai, K. Masuda, S. Toyoshima, S. Kuroki, and S. Ohno, “Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis,” Radiology 200, 639–649 (1996).
39.S. Holm, “A simple sequentially rejective multiple test procedure,” Scand. J. Stat. 6, 65–70 (1979).
40.A. J. Guidi, L. Fischer, J. R. Harris, and S. J. Schnitt, “Microvessel density and distribution in ductal carcinoma in situ of the breast,” J. Natl. Cancer Inst. 86, 614–619 (1994).
41.S. C. Heffelfinger, M. A. Miller, R. Yassin, and R. Gear, “Angiogenic growth factors in preinvasive breast disease,” Clin. Cancer Res. 5, 2867–2876 (1999).
42.S. C. Heffelfinger, R. Yassin, M. A. Miller, and E. Lower, “Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features,” Clin. Cancer Res. 2, 1873–1878 (1996).
44.E. Furman-Haran, F. Kelcz, and H. Degani, “Magnetic resonance imaging of breast cancer angiogenesis: A review,” J. Eval Clin. Pract. 21, 47–54 (2002).
45.S. E. Harms, “The use of breast magnetic resonance imaging in ductal carcinoma in situ,” Breast J. 11, 379–381 (2005).
Article metrics loading...
Full text loading...
Most read this month